Steven M. Ansell
34Patents
20h-index
34Co-inventors
85Inventor score
Filing activity: May 16, 1995 → Mar 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8158601B2 | Lipid formulation | Emerging Cross-Sectional Technologies | 293 | Active |
| US6858225B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 185 | Expired |
| US6287591A | Charged therapeutic agents encapsulated in lipid particles containing four lipid components | Emerging Cross-Sectional Technologies | 125 | Expired |
| US8802644B2 | Lipid formulation | Emerging Cross-Sectional Technologies | 110 | Active |
| US6835395B1 | Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles | Emerging Cross-Sectional Technologies | 110 | Expired |
| US5753613A | Compositions for the introduction of polyanionic materials into cells | Chemistry; Metallurgy | 101 | Expired |
| US9394234B2 | Lipid formulations | Emerging Cross-Sectional Technologies | 99 | Active |
| US9186325B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 89 | Active |
| US7341738B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 87 | Expired |
| US7811602B2 | Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof | Human Necessities | 64 | Active |
| US8021686B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 58 | Active |
| US6320017A | Polyamide oligomers | Chemistry; Metallurgy | 57 | Expired |
| US10166298B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 56 | Active |
| US5785992A | Compositions for the introduction of polyanionic materials into cells | Human Necessities | 48 | Expired |
| US9738593B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 47 | Active |
| US8486924B2 | Taxane delivery system | Chemistry; Metallurgy | 44 | Active |
| US9737619B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 42 | Active |
| US10221127B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 36 | Active |
| US10723692B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 31 | Active |
| US6027726A | Glycosylated protein-liposome conjugates and methods for their preparation | Human Necessities | 27 | Expired |
| US11040112B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 20 | Active |
| US9463247B2 | Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 16 | Active |
| US11168051B2 | Lipids and lipid nanoparticle formulations for delivery of nucleic acids | Chemistry; Metallurgy | 13 | Active |
| US11357856B2 | Lipids for delivery of active agents | Human Necessities | 10 | Active |
| US6586559B2 | Polyamide oligomers | Chemistry; Metallurgy | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.